Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

885 public trials 210 recruiting studies

TDP-43 Proteinopathies trial results

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • L. Boltzmann Forschungsinstitut, Neurologische Abteilung, Kaiser Franz Josef Hospital, Wien Vienna, Austria
  • UCL Saint-Luc Brussels, Belgium
  • UZ Leuven Leuven, Belgium
  • Hopital Roger Salengro - Clinique Neurologique, Neurologie A Lille, France
View all 26 locations
Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Prof. Maloteaux, UCL Saint-Luc Brussels, Belgium
  • Prof. Wim Robberecht, UZ Leuven Leuven, Belgium
  • Prof. Alain Destee, Hopital Roger Salengro - Clinique Neurologique, Neurologie A Lille, France
  • Prof. Philippe Couratier, Hopital Duruytren Limoges, France
View all 25 locations
Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Familial Amyotrophic Lateral Sclerosis, +9 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital-East, Neurology Clinical Trials Unit Charlestown, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Methodist Neurological Institute Houston, Texas, United States
Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States